AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$376M |
| 2 |
Honeywell
HON
|
+$325M |
| 3 |
Progressive
PGR
|
+$288M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$232M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLL
L3 Technologies, Inc.
LLL
|
+$529M |
| 2 |
RTX Corp
RTX
|
+$496M |
| 3 |
CVS Health
CVS
|
+$406M |
| 4 |
US Bancorp
USB
|
+$395M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$279M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.51% |
| 2 | Technology | 14.95% |
| 3 | Healthcare | 13.16% |
| 4 | Industrials | 10.42% |
| 5 | Consumer Discretionary | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Commerce Bancshares
CBSH
$8.53B
| $3.54M | ﹤0.01% |
95,028
-16,449
| -15% | -$555K |
|
|
PEB.PRC
1402
DELISTED
Pebblebrook Hotel Trust 6.50% Series C
PEB.PRC
| $3.54M | ﹤0.01% |
+145,850
| New | +$3.68M |
|
|
BLUE
1403
DELISTED
bluebird bio
BLUE
| $3.53M | ﹤0.01% |
4,417
+77
| +2% | +$61.1K |
|
|
CHS
1404
DELISTED
Chicos FAS, Inc.
CHS
| $3.51M | ﹤0.01% |
243,638
-4,370
| -2% | -$60.3K |
|
1405
Zurn Elkay Water Solutions
ZWS
$8.38B
| $3.49M | ﹤0.01% |
369,871
-624
| -0.2% | -$6.04K |
|
|
OPLN
1406
Openlane
OPLN
$4.21B
| $3.49M | ﹤0.01% |
216,100
-3,424
| -2% | -$54.6K |
|
|
MDP
1407
DELISTED
Meredith Corporation
MDP
| $3.48M | ﹤0.01% |
58,828
-1,120
| -2% | -$58.8K |
|
|
EGN
1408
DELISTED
Energen
EGN
| $3.48M | ﹤0.01% |
60,315
-370
| -0.6% | -$21.1K |
|
|
KNGT
1409
DELISTED
KNIGHT TRANSPORTATION INC
KNGT
| $3.48M | ﹤0.01% |
105,227
| – | – |
|
1410
BGC Group
BGC
$5.45B
| $3.48M | ﹤0.01% |
528,202
| – | – |
|
|
AVP
1411
DELISTED
Avon Products, Inc.
AVP
| $3.47M | ﹤0.01% |
689,194
-11,048
| -2% | -$64.2K |
|
|
ALR
1412
DELISTED
Alere Inc
ALR
| $3.47M | ﹤0.01% |
89,127
+33,819
| +61% | +$1.37M |
|
1413
Gentex
GNTX
$4.97B
| $3.47M | ﹤0.01% |
176,327
-3,486
| -2% | -$63.5K |
|
|
FSP
1414
Franklin Street Properties
FSP
$47.2M
| $3.47M | ﹤0.01% |
267,541
-94,081
| -26% | -$1.14M |
|
1415
Granite Construction
GVA
$5.29B
| $3.46M | ﹤0.01% |
62,949
-190,135
| -75% | -$10.1M |
|
1416
Southern First Bancshares
SFST
$591M
| $3.46M | ﹤0.01% |
96,065
+100
| +0.1% | +$3.01K |
|
|
SCLN
1417
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $3.46M | ﹤0.01% |
319,998
+1,890
| +0.6% | +$18.9K |
|
|
AAT
1418
American Assets Trust
AAT
$1.45B
| $3.45M | ﹤0.01% |
80,137
-1,015
| -1% | -$41.4K |
|
1419
SouthState Bank Corp
SSB
$10.2B
| $3.44M | ﹤0.01% |
39,418
-700
| -2% | -$56.6K |
|
1420
Capitol Federal Financial
CFFN
$1.09B
| $3.44M | ﹤0.01% |
209,026
| – | – |
|
1421
Wayfair
W
$11.2B
| $3.44M | ﹤0.01% |
98,050
+53,650
| +121% | +$1.93M |
|
1422
Ionis Pharmaceuticals
IONS
$8.6B
| $3.43M | ﹤0.01% |
71,717
-3,502
| -5% | -$139K |
|
1423
Archrock
AROC
$6.27B
| $3.42M | ﹤0.01% |
259,360
| – | – |
|
1424
Patrick Industries
PATK
$2.74B
| $3.42M | ﹤0.01% |
100,913
-12,262
| -11% | -$362K |
|
1425
Lamb Weston
LW
$7.22B
| $3.42M | ﹤0.01% |
+90,300
| New | +$3.08M |
|
Similar funds
AllianceBernstein's Q4 2016 Portfolio in Review
As of Q4 2016, AllianceBernstein held 3,102 positions worth $120B, up 1.3% from $118B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AllianceBernstein's Q4 2016 filing shows 125 new, 894 increased, 1,362 reduced and 90 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 754,842 shares worth $83.2M. The largest sale was L3 Technologies, Inc., an estimated $529M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
- AllianceBernstein's largest Q4 2016 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 754,842 shares worth $83.2M.
- AllianceBernstein added most to Edwards Lifesciences in Q4 2016, an estimated $376M increase.
- AllianceBernstein's biggest Q4 2016 reduction was L3 Technologies, Inc., cutting an estimated $529M.
- AllianceBernstein fully exited Amsurg Corp in Q4 2016, selling an estimated $89.6M.
- AllianceBernstein's ten largest holdings make up 14% of its $120B portfolio in Q4 2016.
- AllianceBernstein opened 125 new positions and closed 90 in Q4 2016.
- AllianceBernstein's portfolio value rose 1.3% quarter-over-quarter to $120B.
Based on AllianceBernstein's 13F filing for Q4 2016, filed 13 Feb 2017.